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1 Introduction 
1.1 C-H bond activation 
The vast majority of organic compounds and materials are derived from non renewable 
sources as natural gas or petroleum. The major constituents of these feedstocks are 
hydrocarbons. These molecules are constituted by strong and localized C-C and C-H 
bonds, so that the molecules have no empty orbitals of low energy or filled orbitals of 
high energy, that could readily participate in a chemical reaction. This feature is the 
reason of their chemical inertness and very few processes to convert hydrocarbons into 
more valuable compounds exist. 
Nowadays hydrocarbons are mainly used in combustion reactions, to exploit their energy 
content. On industrial scale cracking and thermal dehydrogenation convert alkanes to 
valuable olefins, but these processes require high temperatures and are energy intensive. 
Alkanes can also react by exposure to highly reactive species such as superacids or free 
radicals. However these species are usually demanding and expensive to make, and offer 
little control over product selectivity. Milder and better-controlled direct conversions of 
alkanes into olefins and other higher value chemicals, may thus offer large economic 
benefits. 
To reach this goal, the strong C-H bond of hydrocarbons (bond dissociation energy: 105 
kcal/mol for H-CH3), must be activated somehow. The activation consists in the increase 
of the reactivity of the C-H bond toward a reagent. As a consequence, the bond is capable 
of splitting to produce two particles in place of the single initial species. The main result 
of activation of a C-H bond is the replacement of a strong C-H bond, with a weaker, 
more functionalized bond
1
. 
The activation of unsaturated species like olefins or arenes, can be induced by the 
interactions of π-orbitals with empty orbitals of a transition metal centre. Saturated 
molecules don´t have this possibility, so that activation of aliphatic C-H bonds at 
transition-metal centres, would not be a good strategy for catalytic alkane conversion. 
However, during the 1970s, examples
2
 of interaction between a metal centre and an 
alkane C-H bond suggested that this difficulty might have been overestimated. The 
chemists suggested that C-H activation might take place yielding a thermodynamically 
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unstable and thus undetectable organometallic product. In 1982, two groups
3,4
 
independently demonstrated intermolecular alkane activation (figure 1). 
Figure 1 – Intermolecular alkane activation. 
 
Despite these accomplishments, the development of practical alkane conversion poses 
further challenges
5
. One is activity, as only reactions proceeding at an adequate rate will 
be useful. Second problem is selectivity, arising from the relative reactivity of different 
C-H bonds (terminally functionalized alkanes are the most desirable products). Finally, 
thermodynamics presents a hurdle to an overall alkane conversion. Transformations such 
as dehydrogenation or carbonylation, are thermodynamically uphill near room 
temperature. 
The nature of C-H bond metalation
5
 varies depending on the substrate, the solvent and 
the transition metal, but four main mechanisms are identified: σ-bond metathesis for 
metals from group 3 of the periodic table (Sc, lanthanides and actinides); oxidative 
addition typical of electron-rich, low-valent complexes of the late transition metal (Re, 
Fe, Ru, Os, Rh, Ir, Pt); electrophilic metalation with a late or post transition metal; Lewis 
base assisted deprotonation (scheme 1). 
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Scheme 1 - Main mechanisms in C-H bond metalation. 
 
1.2 C-H bond activation in organic chemistry 
Over the decades, developments in organic chemistry enabled the production of a vast 
number of compounds. Chemists usually prepare molecular structure by the 
interconversion of functional groups, which are moieties exhibiting relatively high 
chemical reactivity (figure 2). The reactive sites are typically incorporated in the 
molecules by means of multiple transformations, which are often wasteful in time and 
money. 
Figure 2 - A: traditional approach to organic synthesis by means of functional group (FG); B: 
synthesis by means of C-H bond functionalization. 
 
In this context the direct transformation of C-H bonds, would be an efficient and useful 
tool in organic synthesis. In the last 15 years, the C-H bond activation followed by 
functionalization has emerged has a revolutionary trend in organic field. This rush has 
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led to the development of a wide range of reactions aimed at directly installing new C-C 
or C-X bonds. 
Chemists encountered two main problems in studying the C-H bond functionalization. 
First, the reactivity: the strength of C-H bond (figure 3), leads to a large kinetic barrier 
associated with the C-H bond cleavage. Second, the regioselctivity: most molecules 
contain different types of C-H bond and the selective functionalization of a specific C-H 
bond is still a challenge. To obtain products with a predictable regioselectivity, a number 
of approaches have been used: the use of substrates containing activated or weaker C-H 
bonds (e.g. benzylic or allylic systems); the use of coordinating ligands within a substrate 
as a directing group; carrying out intramolecular reaction via favourable five- or six-
membered transition states; the use of transition metal catalysts/ligand to control the 
stereoselectivity. 
Figure 3 – Bond dissociation energies of C-H bond (kcal/mol). 
 
Undeniably, the direct transformation of C-H bonds provides shortcuts compared with 
classical organic synthesis, thus rendering synthetic routes more straightforward and 
atom-economical. A prime example is the synthesis of the biaryl structural motif, which 
is a common feature in pharmaceutical and biological compounds. To date, biaryl 
moieties are mostly obtained by Suzuki-Miyaura, Mizoroki-Heck, Negishi and Stille 
coupling reactions. Typically these reactions involve the coupling of an aryl halide with 
an organometallic reagent. The preparation of the preactivated aryl substrate often 
requires several steps, which can be time consuming and economically inefficient. An 
alternative to this approach is to consider the C-H bond activation. In this case, only one 
coupling reagent is preactivated, while the other reagent is a simple unactivated aryl 
substrate, resulting in the elimination of the activation steps for one of the arylic 
substrates (figure 4). 
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Figure 4 - Biaryl synthesis. A: cross coupling reactions; B: C-H bond activation. 
 
 
Even more alluring is that this new approach enables previously unachievable synthetic 
disconnections. For this reason C-H functionalization strategies have been incorporated 
into the synthesis of complex natural products and biologically active molecules. For 
example, the synthesis of racemic austamide (1), by Hutchinson and Kishi
6
 in 1979 was 
completed in 29 steps, whereas that of (+)-1 in 2002 by Baran and Corey
7
 based on C-H 
alkylation took only 5 steps (figure 5). Another striking comparison is a 67-steps 
synthesis of (-)-tetrodotoxin (2) published by Isobe and co-workers
8
 in 2003, versus the 
32-steps synthesis by Hinman and Du Bois
9
 that made use of a C-H insertion and 
amination methods (figure 5). 
Figure 5 – Examples in the evolution of the synthesis of biologically active compounds with the 
advent of C-H functionalization. 
 
In many organic fields, the search for optimal compound imposes an optimization of 
target molecules that show interesting characteristics. The enhancement of the properties 
is accomplished by the modification of the chemical structure of the molecule, provided 
A 
B 
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that the basic scaffold must not be modified. Since it´s impossible to know in advance 
which substituent would increase most the properties of the target molecule, a wide range 
of related analogues should be synthesized and tested. In this context, chemists use a 
synthetic strategy called “late stage functionalization”: this approach enables the 
insertion of functional group in the final steps of the synthesis of a compound. Owing to 
the omnipresence of C-H bonds in all kinds of organic molecules, the ability to transform 
selectively, efficiently and in a predictable manner a specific C-H bond opens the door 
for the almost unlimited exploitation of this strategy for the late stage modification of 
various compounds
10
 (figure 6). This approach surpasses de novo synthesis strategies not 
only by shortcutting the laborious and time-consuming preparations of each analogue, 
but also giving the opportunity to install functional groups that could be incompatible 
with standard synthetic sequences. 
Figure 6 – Late stage functionalization by means of C-H bond activation.  
 
1.3 C-H activation for the constructions of C-B bond 
Organoboron compounds are very useful in organic synthesis, not only because they are 
very versatile in cross-coupling reactions but also because a wide range of transformation 
of boronate molecules has been developed (oxidation, halogenation, amination and 
etherification). 
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For these reasons the direct transformation of C-H bonds to C-B bonds in alkanes, 
alkenes and arenes, has made great progresses. In the last twenty years, this reaction has 
developed from stoichiometric reactions of transition metal-boryl complexes to metal-
catalyzed system leading to organoboron compounds in high yield and high selectivity. 
The conversion of C-H bonds to C-B bonds is both thermodynamically and kinetically 
favourable (figure 7). On the basis of calculated bond energies, the reaction at a primary 
C-H bond of methane or a higher alkane with B2(OR)4, is thermodynamically downhill
11
. 
Figure 7 – Thermodynamics of methane borylation with B2(OR)4. 
 
One of the most difficult problems in C-H bond activation is the selective 
functionalization of primary C-H bond in alkanes. Primary C-H bonds are stronger than 
secondary or tertiary ones, thus reactions like halogenation or autoxidation occur at the 
internal position of alkanes. 
In 1999 Hartwig and co-workers
12
 reported a reaction between alkanes and 
bis(pinacolato)diboron (B2Pin2) to form an alkylboronate ester. The transformation was 
catalyzed by the metal complex Cp*Re(CO)3, stabilized by 2 atm of CO. The reaction 
occurred with perfect regioselectivity leading to functionalized product at primary C-H 
bond. In addition to alkenes, alkyl ethers underwent borylation at the least sterically 
hindered terminal methyl groups in moderate to excellent yields (scheme 2). 
Scheme 2 – Cp*Re-catalyzed borylation of alkanes. 
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After a series of experiments, a mechanism for the borylation reaction (scheme 3), was 
proposed. After the photochemical dissociation of CO, B2Pin2 undergoes oxidative 
addition to form the intermediate Cp*Re(CO)2(Bpin)2. Following the dissociation of 
another molecule of carbon monoxide, the resulting unsaturated bisboryl complex reacts 
with alkane, leading after reductive elimination to the observed alkylboronate ester 
product. 
Scheme 3 – Proposed mechanism for Cp*Re-catalyzed alkane borylation. 
 
In 2000, Chen and Hartwig
13
 tested a series of Cp*ML2 complexes that catalyze the 
borylation of alkene under thermal conditions. Cp*Rh(η
4
-C6Me6) was found to be the 
best complex, as the hexamethylbenzene ligand was resistant to C-H bond 
functionalization, and the reaction of octane with B2Pin2 catalyzed by 5 mol% of 
Cp*Rh(η
4
-C6Me6) provided high yield (88%) of octylBpin. This complex also catalyzes 
the borylation of terminal methyl groups in alkanes, alkyl ethers, tertiary amines and 
partially fluorinated alkanes (scheme 4). When a molecule includes a heteroatom, the C-
H bond α to the heteroatom is activated toward cleavage by many metal complexes
14
. 
However, this property of heteroatom did not override the preference of the catalyst for 
the functionalization of the least hindered of the primary C-H bond. 
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Scheme 4 – Scope of Cp*Rh(η
4
-C6Me6) catalyzed borylation of aliphatic substrates. 
 
Arylboronates are widely used in synthesis
15
 and most of them are prepared from aryl 
halides (scheme 5). As a consequence, the range of arylboronates available depends on 
the availability of the substituted aryl halides. The development of methods for the direct 
transformation of C-H bonds to C-B bonds, reduces steps in arylboronate synthesis and 
provides access to isomers of arylboronates that would be difficult to access otherwise. 
Scheme 5 – Common synthesis of arylboronate esters and acids. 
 
The first arene borylation reactions
16,17
 were accomplished using Cp*Rh and Cp*Ir 
complexes as catalysts. Later, Smith and co-workers
18
 obtained good results with a 
combination of (Ind)Ir(COD) (Ind: indenyl; COD: cyclooctadiene) and phosphine 
ligands. However a big breakthrough was in 2002, when Ishiyama, Miyaura, Hartwig and 
co-workers
19
 reported the borylation of arenes catalyzed by iridium complexes of 
bipyridine (bpy). An optimization of the catalyst
20
 was conducted and [Ir(COD)(OMe)]2 
(figure 8a), was found to be the best Iridium(I) precursor. Different substitued bipyridine 
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were tested as ligand. Due to steric effects the best pattern was found for 4,4´-
disubstituted-2,2´-bipyridine
20
. Using this pattern, electronic effects of the bipyridine 
ligand on borylation were tested. When bpy contained electro-donating group such as 
NMe2, OMe or tBu the borylation reaction occurred in high yield; on the other hand with 
electron-withdrawing group such as Cl and NO2, no product was observed. After these 
experiments the best ligand was found to be 4,4′-Di-tert-butyl-2,2′-dipyridyl
20
 (dtbpy) 
(figure 8b). 
Figure 8 – a: [Ir(COD)(Ome)]2; b: 4,4′-Di-tert-butyl-2,2′-dipyridyl. 
 
A variety of arenes reacted with B2pin2 at room temperature to form arylboronate esters 
with the [Ir(COD)(OMe)]2 (OMe: methoxy) and dtbpy system
20
 (table 1). A number of 
functional group was tolerated and also heteroaromatic molecules reacted. The 
regioselectivity of the reactions catalyzed by dtbpy-ligated iridium was controlled by 
steric effects. 
Table 1 – Arene borylation with B2Pin2 catalyzed by [Ir(COD)(OMe)]2 and dtbpy. 
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On the basis of data obtained from NMR spectroscopy of catalytic system, isolation of 
intermediates and kinetic data, Hartwig and co-workers proposed the mechanism
19,21
 
shown in scheme 6 for the borylation of arenes catalyzed by dtbpy-ligated complexes of 
iridium (in the experiments [Ir(COE)2Cl]2, COE: cyclooctene, was used as metal 
precursor). Since the reaction is inhibited by adding COE, the first step is the reversibly 
dissociation of COE from the stable tris boryl complex. The resulting 16 electrons 
complex, which is the real active form of the catalyst, coordinates the arene and then the 
oxidative addition of the aryl C-H bond occurs to form an iridium(V) intermediate. The 
cleavage of the aryl C-H bond is the turnover-limiting step in the formation of the 
arylboronate ester. Reductive elimination of Ph-Bpin, followed by oxidative addition of 
B2Pin2 would then regenerate the active iridium trisboryl complex. 
Scheme 6 – Proposed mechanism for the iridium-catalyzed borylation of arenes. 
 
The regioselectivity controlled by steric effects, complements the regioselectivity of most 
other types of arene functionalization. Nevertheless a method to accomplish different 
regioisomers would be a valuable tool. In 2008 Hartwig and co-workers
22
 described the 
selective ortho-borylation of arenes catalyzed by the combination of [Ir(COD)Cl]2 and 
dtbpy (scheme 7). In this method, the borylation of arenes was directed to the ortho 
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position by a dialkyl hydrosilyl group. This method provides a mild alternative to ortho-
metalation methods based on alkyl lithium or magnesium reagents
23
. 
Scheme 7 – ortho-directed arene borylation observed with benzyilic dimethylsilanes as substrates. 
 
The mechanism envisioned for this ortho-borylation is shown in scheme 8. Following the 
COE dissociation, the elimination of Hbpin leads to a bisboryl silyl species. Then this 
intermediate will cleave the aryl C-H bond in the ortho position. C-B bond formation and 
further reductive elimination of the silane would release the functionalized product. 
Scheme 8 – Proposed mechanism for hydrosilyl-directed ortho-borylation of alkylarenes. 
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In 2009 Sawamura and co-workers
24
 reported the reaction of methyl benzoates with 
B2Pin2, catalyzed by the combination of [Ir(COD)(OMe)]2 and the silica-supported 
monodentate, electron-rich, and compact phosphine ligand SMAP (a silica-supported 
phosphine ligand). Excellent regioselectivity, under mild condition was observed, 
resulting in ortho-directed borylation of the substrates. Moreover reactions of arenes 
containing CO2Et, CO2tBu, CONMe2, SO3Me, CH(O(CH2)3O) led to the ortho-borylated 
product, showing the efficacy of these substituent as directing group. In 2011 Sawamura 
and co-workers
25
, using again silica-supported phosphine ligand, described a different 
method for ortho-borylation of arenes. The catalyst was [Rh(OH)(COD)]2 and the arenes 
contain different nitrogen-based directing group such as pyridine and pyrazole. 
A more general approach for the iridium-catalyzed ortho-borylation of arenes was 
reported by Ros and co-workers
26
 in 2011. As shown earlier, the direct borylation of 
arene with the iridium/dtbpy system, takes place through a [Ir(dtbpy)(Bpin)3] 16 
electrons catalytically active species A (scheme 9). 
Scheme 9 – Analysis of regioselectivity in Ir-catalyzed borylations. 
 
The lack of sensitivity of this process towards any directing group in the substrate, can be 
attributed to the lack of additional vacant coordination sites in complex B. In this 
scenario, the reaction can only proceed via intermediate C, and steric factors represent 
the main contribution to regioselectivity. As a consequence, if vacant coordination site 
can be generated in the metal complex, a new reaction pathway could be created. As an 
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example, when the dtbpy ligand is replaced by a hemilabile N,N ligand (scheme 10), the 
properties of this latter ligand should facilitate the temporary generation of a 
coordinatively unsaturated intermediate III from the established catalytic species I, via 
complex II. This complex III undergoes oxidative addition of the ortho C-H bond of the 
arene, followed by reductive elimination and recoordination of the hemilabile ligand, 
leading to product and to regenerate catalyst I. 
Scheme 10 – Envisaged mechanism using hemilabile N,N-ligands. 
 
In particular, picolinaldheyde N.N-dibenzylhydrazone L1 combined with [Ir(μ-
OMe)(COD)]2 proved to be a very efficient ligand for the borylation of 1-
naphtylisoquinolines and 2-arylpyridines with B2Pin2 under mild conditions
27
 (scheme 
11). 
16 
 
Scheme 11 – Directed borylation of arylpyridines/isoquinolines. 
 
To exploit the original regioselectivity of the iridium-catalyzed borylation, a wide range 
of derivatization of the boronate esters has been developed (scheme 12). The boronate 
esters product can be used in Suzuki cross-coupling, resulting in biphenyl motifs that are 
very useful in medicinal chemistry. Other common transformations include oxidation, 
halogenation, cyanation, Chan-Lam-Evans
28
 amination and etherification, hydrolysis and 
trifluoroborate formation. 
Scheme 12 – Derivatization of boronate esters. 
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1.4 Indazole and pyrazolopyrimidine 
1.4.1 Indazole 
Indazole is a heterocycle molecule in which a pyrazole ring is fused with a benzene ring 
(figure 9). Indazoles are naturally occurring alkaloids. Indazoles derivatives are 
pharmacologically important as they form the basic structure of several drug molecules. 
They possess several activities such as anti-inflammatory, anti-tumor, anti-HIV, anti-
platelet and serotonin 5-HT3 receptor antagonist activities
29
. 
Figure 9 – Indazole. 
 
Indazole is a ten π-electron aromatic heterocycle system, resembling both pyridine and 
pyrrole and its reactivity reflects this dual behaviour. The indazole ring has two nitrogen 
atoms and presents annular tautomerism with regards to the position of the NH hydrogen 
atom (figure 10). Due to the difference in energy between the tautomers, the 1H-tautomer 
(1) predominates in the gas phase, solution and solid state and its derivatives are usually 
thermodynamically more stable then the corresponding 2H-form (2). 
Figure 10 – Annular tautomerism of indazole. 
 
An important class of indazoles are the 3-aryl-1H-indazoles (figure 11). The common 
synthesises of these compound include the condensation of hydrazines with 
fluorobenzophenones
30
, diazomethane cycloaddition with benzynes
31
, C-H amidation of 
aryl hydrazones
32
 or catalytic N-N bond formation
33
. In these cases the diversity of 
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substitution on both the indazole and the aryl group must be introduced early in the 
synthetic sequence. Moreover, these methods require the use of either explosive or toxic 
reagents. 
Figure 11 – Bioactive 3-aryl-1H-indazoles. 
 
As results, chemists have developed different methods for the direct arylation of 1H-
indazoles via C-H activation. However, due to the lack of reactivity at 3-position of 
indazole, a first example of arylation was reported only in 2013. Yu and co-workers
34
 
reported the reaction of 1-protected-1H-indazole, catalyzed by Pd
II
 using phenantroline 
as ligand (scheme 13). Different protecting group were tested: electron-withdrawing 
protecting group such as Ac, Boc and Ts inhibit the reaction severely, while alkyl 
protecting group such as Bn, SEM and THP are compatible with this reaction. Aryl 
iodides and bromides worked well and on the aryl-halides a wide range of functional 
group was tolerated (both electron-donating and withdrawing). 
Scheme 13 – Direct arylation of 1H-indazoles at 3-position. 
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However the conditions reported require high temperature (up to 160 °C), and long time. 
In 2014, Burton and Egan
35
 described the synthesis of 3-aryl-1H-indazoles via iridium-
catalyzed C-H borylation and Suzuki-Miyaura coupling. The catalytic system was 
formed by [Ir(COD)(OMe)]2 and dtbpy as ligand. The substrate tested was the 1-methyl-
1H-indazole and mild conditions for the borylation reaction were used (55 °C for 1,5 
hours). A useful one-pot tandem reaction sequence was developed (scheme 14). A wide 
range of aryl iodides, chlorides and bromides containing both electron-donating and –
withdrawing group all reacted in good yield. 
Scheme 14 – One pot indazole borylation and Suzuki-Miyaura coupling. 
 
1.4.2 Pyrazolopyrimidine 
The word “pyrazolopyrimidine” refers to a class of compound in which a pyrazole 
molecule is fused with a pyrimidine ring. Thus, different combinations are possible, 
resulting in different molecules such as pyrazolo[3,4-d]pyrimidine, pyrazolo[4,3-
d]pyrimidine, pyrazolo[5,1-b]pyrimidine, pyrazolo[1,5-a]pyrimidine, that are contained 
in many drugs
36
 (figure 12). 
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Figure 12 – Pyrazolopyrimimidine scaffolds in common drugs. 
 
Among these compounds, pyrazolo[3,4-d]pyrimidine has a great importance since its 
structure (figure 13), is an isostere of adenine, which is fundamental for every aspect of 
cell life as a constituent of DNA and RNA. Pyrazolo[3,4-d]pyrimidines are active in the 
inhibition of tyrosine or serine/threonine kinase and they also have antimicrobials, 
anticancer and anti-inflammatory properties. 
Figure 13 – 1H-Pyrazolo[3,4-d]pyrimidine. 
 
A wide range of synthetics strategies have been developed to arrange substituted 
pyrazolo[3,4-d]pyrimidine at different position, starting from either the pyrimidine or the 
pyrazole nucleus. The most common route to this scaffold is the method reported by 
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Robin
37
 in the mid-1950s (scheme 15). Reaction of ethoxymethylenemalononitrile 1 with 
hydrazine monohydrate without solvent or with different substituted hydrazines in 
refluxing ethanol, produced 5-amino-1H-pyrazole-4-carbonitriles 2a-d and similar 
derivatives, which were then hydrolyzed with concentrated sulphuric acid to the 
corresponding amides 3a-d. These amides where subsequently cyclised into the 
corresponding 1H-pyrazolo[3,4-d]pyrimidin-4-ols 4a-d by treatment with boiling 
formamide. C4 chlorination of the latter compounds with POCl3 gave 5a-d, which 
underwent nucleophilic displacement of the chlorine atom by primary or secondary 
amines in refluxing alcoholic solution to afford the 4-amino derivatives 6. A method
38
 for 
obtaining 1,6-alkyl/aryl disubstituted 1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones 87 is 
represented by the straightforward reaction of carboxamides 3b,c with different esters in 
the presence of sodium ethoxide in ethanol (scheme 16). 
Scheme 15 – Synthesis of 4-amino-substituted 1H-pyrazolo[3,4-d]pyrimidine. 
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Scheme 16 – Synthesis of 1,6-disubstituted 1H-pyrazolo[3,4-d]pyrimidin-4-ones. 
 
The synthesis of pyrazolo[3,4-d]pyrimidine scaffold can also start from pyrimidine ring, 
although this procedure has been using less than cyclization starting from pyrazole 
intermediate. The synthesis
39
 generally involves reaction of pyrimidines possessing a 
carbonyl function at 5-position with hydrazine derivatives. 2-amino-4,6-dichloro-
pyrimidine-5-carbaldehyde 97 was cyclised with hydrazine hydrate to give 4-chloro-1H-
pyrazolo[3,4-d]pyrimidin-6-amine 98 (scheme 17). 
Scheme 17 – Synthesis of 4-chloro-1H-pyrazolo[3,4-d]pyrimidin-6-amine starting from 2-amino-4,6-
dichloro-pyrimidine-5-carbaldehyde. 
 
2 Project 
In drug discovery, a “lead compound” is a chemical compound that shows desired 
pharmacologically or biologically activity on a validated molecular target, but it could 
still have suboptimal features. The properties of the lead compound can be influenced by 
chemical modification, using the lead chemical structure as starting point. The aim is to 
generate analogues of the initial lead with improved potency, reduced off-target activities 
and desirable physiochemical/metabolic properties. Usually, hundreds of different 
variations are made and tested in biological systems providing additional information for 
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the chemists. Therefore, the design of methods permitting the direct transformation of a 
lead compound, in analogue scaffolds with slightly modified structure, is highly 
desirable. In this context, predictable, efficient and both chemo- and regioselective 
transformations of specific C-H bonds applied to a late stage functionalization strategy, is 
particularly appealing. 
The project described in this report, was developed in AstraZeneca´s laboratories, at 
Mölndal (Sweden) research and development site. In this case, the lead compound at the 
heart of the project is shown in figure 14. Due to patent issues, the amine moiety at 4-
position is masked. The molecule consists of a pyrazolo[3,4-d]pyrimidine scaffold, 
substituted at 1-position with a p-fluorophenyl moiety. 
Figure 14 – 1-phenyl-1H-pyrazolo[3,4-d]pyrimidine. 
 
The lead optimization process requires the screening of a wide range of functionalized 
compound, that are synthesized from 1-phenyl-1H-pyrazolo[3,4-d]pyrimidine. In order to 
save time and money, a general but chemo- and regioselective procedure leading to a 
large panel of analogues, needs to be developed. The project aims to develop a protocol 
for the metal-catalyzed C-H borylation of 1-phenyl-1H-pyrazolo[3,4-d]pyrimidine and to 
demonstrate its applications to the late stage functionalization. 
In the last years, efficient methods for metal-catalyzed borylation reactions, have been 
developed and many metal-ligand combinations have been screened. The first 
combination chosen in the project was composed by [Ir(COD)OMe]2 (bis(1,5-
cyclooctadiene)di-iridium(I)-dimethoxide) and dtbpy (4,4′-di-tert-butyl bipyridine) as 
ligand (figure 15). This system has been reported to be very active in the borylation of 
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arenes and heteroarenes. Moreover, Burton
35
 described the borylation of 1-methyl-1H-
indazole at 3-position with this system under mild condition (55 °C, overnight, MTBE as 
solvent). Indazoles have a structure similar to that of pyrazolo[3,4-d]pyrimidine since 
they share a pyrazole ring, fused with an aromatic system and their C-H borylation has 
been reported. For these reasons, the scope of the borylation reaction will be broadened 
to 1-susbstituted-1H-indazoles, in order gather more data. The second ligand chosen was 
the Me4phen (3,4,7,8-tetramethyl-1,10-phenantroline) (figure 15). Me4phen has grater 
electron-donating ability and backbone rigidity compared to those of dtbpy. Its activity in 
borylation of heteroarenes was reported by Hartwig
40
 in 2014. 
The reaction condition (time, temperature, solvent), were taken from the already cited 
papers by Burton and Hartwig. 
Figure 15 – The iridium complex and the ligands chosen for borylation experiments. 
 
During the development of the borylation method for this kind of substrates, two main 
problems usually arise. First, since 1-phenyl-1H-pyrazolo[3,4-d]pyrimidine contains 
three different C-H bond, the selective activation of one of those bond must be achieved. 
Second, the basicity of the nitrogen at 2-position of the pyrazole ring could lead to a non-
productive coordination between the heteroatom and the metal catalyst. However, the 
reaction protocol will be aimed to obtained specific regioselectivity. 
Application of C-H borylation to late stage functionalization will be demonstrated by 
converting the borylated intermediate: the boronic ester will be transformed into an 
alcoholic moiety through an oxidation reaction, using sodium perborate. 
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3 Results and discussion 
3.1 Synthesis of substrates 
In the beginning, most of the time was dedicated to the synthesis of the substrates that 
were used in the borylation experiments. The synthesis of the pyrazolopyrimidine 
scaffold was accomplished by the reaction of a carboxamides 2a, 2b with esters 3a, 3b, 
in presence of sodium ethoxide and ethanol as solvent (scheme 18). The reactions were 
conducted in a microwave reactor using a 5 ml vial. Product 5 and 6 were obtained in 
good yield, but due to low solubility in MTBE and THF, these two compounds were 
discharged. 
Scheme 18 – Synthesis of pirazolopyrimidine on a 5 ml scale. 
a
 Reaction run on a 13 ml scale. 
 
Compound 4 showed good features and the synthesis was scaled up to a 20 ml 
microwave vial, using 750 mg of starting material. The yield varied from 52% to 59%. 
Nevertheless, the need for a bigger amount of product, required an increase in the 
reaction scale. Therefore, the reaction between 5-amino-1-(4-fluorophenyl)-1H-pyrazole-
4-carboxamide (1500 mg) and ethyl pivalate, was carried out in a  two neck 100 ml 
round bottom flask and kept under reflux for 24 h (scheme 19). 6-tert-butyl-1-(4-
fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one (4) was isolated to give a 46% 
yield. 
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Scheme 19 – Synthesis of 6-tert-butyl-1-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one. 
 
The following step, was the synthesis of the lead compound 1-phenyl-1H-pyrazolo[3,4-
d]pyrimidine, through a C-N cross coupling reaction between compound 4 and an amine 
(scheme 20). The reaction worked well both with piperidine (to give product 7 in 72% 
yield), and with the masked amine to give the product of interest (1) in Astrazenca´s 
project (89% yield). 
Scheme 20 – C-N cross coupling reaction. PyBOP: benzotriazol-1-yl-oxytrpyrrolidinophosphonium 
hexafluorophosphate; DBU: 1,8-diazobicyclo[5.4.0]undec-7-ene; DMF: dimetilformammide. 
 
On the other hand, the indazoles used in the experiments were purchased or taken from 
an in-house source. 
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3.2 Borylation experiments 
In the first part of this work, two different reaction conditions were used to perform 
borylation: 
- B2Pin2 as boron source; a combination of [Ir(COD)OMe]2 (bis(1,5-
cyclooctadiene)di-iridium(I)-dimethoxide) and dtbpy (4,4′-di-tert-butyl 
bipyridine) as catalyst; MTBE as solvent; 
- B2Pin2 as boron source; a combination of [Ir(COD)OMe]2 (bis(1,5-
cyclooctadiene)di-iridium(I)-dimethoxide) and Me4phen (3,4,7,8-tetramethyl-
1,10-phenantroline) as catalyst; THF as solvent. 
We began our studies by employing these conditions to substituted indazoles and a 
pyrazolopyrimidine system (table 2). Comparing the crude product NMR with the 
starting material NMR, no conversion for all the experiments was observed. Except for 
entries 2a and 4a, where the low solubility of the substrates in MTBE was an issue, the 
poor results can be explained with the instability of the catalyst in oxygen. During the 
preparation of the reaction mixture, the metal-ligand complex was exposed to air oxygen, 
causing its deactivation. 
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Table 2 – Borylation of indazoles and pyrazolopyrimidine system. 
 
Entry Substrate x Ligand Temperature Solvent Conversion 
1a
a 
 
0.5 dtbpy 55 °C MTBE 0% 
1b
b 
1 Me4phen 80 °C THF 0% 
2a
a 
 
0.5 dtbpy 55 °C MTBE 0% 
2b
b 
1 Me4phen 80 °C THF 0% 
3a
a 
 
0.5 dtbpy 55 °C MTBE 0% 
3b
b 
1 Me4phen 80 °C THF 0% 
4a
a 
 
0.5 dtbpy 55 °C MTBE 0% 
4b
b 
1 Me4phen 80 °C THF 0% 
a Reaction conducted on a 0.6 mmol scale, 0.2 M. b Reaction conducted on a 0.5 mmol scale, 0.5 M. 
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In order to confirm this hypothesis, further experiments were performed with 1-methyl 
indazole (13) as substrate (table 3). Substrate 13 was chosen, since borylation 
experiments on this compound are reported in literature. 
Table 3 – Borylation  of 1-methyl indazole. 
 
Entry x Ligand Temperature Solvent Glovebox Conversion 
1
a 
0.5 dtbpy 55 °C MTBE Out 48% 
2
b 
0.5 dtbpy 55 °C MTBE In 58% 
3
c 
1 Me4phen 80 °C THF Out 0% 
4
c 
1 Me4phen 80 °C THF In 80% 
a Reaction conducted on a 0.3 mmol scale, 0.1 M. b Reaction conducted on a 0.6 mmol scale, 0.2 M. c 
Reaction conducted on a 0.5 mmol scale, 0.5 M. 
When the experiments were set up outside the glovebox, we got different results. With 
dtbpy as ligand and MTBE as solvents (entry 1), the conversion was 48% (reactivity of 
1-methyl indazole under these conditions was reported in literature). If Me4phen and 
THF were used, no conversion was observed. On the other hand, an improvement of 
conversion was obtained by working inside the glovebox: for the dtbpy system (entry 2) 
the conversion increased from 48% to 58%, while for the Me4phen ligand (entry 4) the 
increase was from 0% to 80%. 
These results confirmed the need to avoid the contact with oxygen, while preparing the 
reaction mixture. Furthermore, considering the value of conversion and the solubility 
issue with MTBE, the combination of [Ir(COD)OMe]2, Me4phen and THF was found to 
be a better system for borylation. 
For these reasons, the following reactions were set up inside the glovebox and dtbpy and 
MTBE weren´t used anymore. 
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By NMR analysis of 13a, it was possible to state that the borylation occurred at 3-
position of the 1-methyl indazole (consistent with literature findings
35
). 
Later, borylation was tested on pyrazolopyrimindine 4 (scheme 21): the conversion was 
57% and product 4a was obtained in a 10% yield. The low value of yield was due to an 
inefficient purification process and to the presence of many side products. Since in 
substrate 4 three different C-H bond can be activated, a structure elucidation was done to 
figure out what regioisomer was obtained. From 
1
H NMR, the presence of the signal of 
the hydrogen at the 3-position and the integration of the aromatic signal, suggested that 
the borylation occurred in the phenyl substituent. The high resolution 
13
C NMR revealed 
the coupling between the fluorine atom and the carbon atoms in the aromatic substituent. 
Therefore, exploiting the values of coupling constants and COSY, HSQC and HMBC 
analysis, was possible to identify the molecule 4a as the ortho regioisomer. 
Scheme 21 – Borylation of 6-tert-butyl-1-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one. 
 
Thereafter we turned our attention to a tandem reaction sequence (scheme 22). We 
decided to use the crude product of the borylation reaction to run an oxidation
40
 with 
sodium perborate, in order to convert the boronic ester into an alcoholic moiety. The 
choice to conduct these tandem reactions was made to showcase the potential of late 
stage activation. Moreover, the borylated products are not very stable because of 
hydrolysis reaction, thus arising problems in the analysis step (especially in NMR and 
LC-MS). 
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Scheme 22 – Tandem reaction on heterocycle: borylation followed by oxidation. 
 
First, we went back to 1-(4-fluorophenyl)-1H-indazole-5-carbonitrile (10) and 1-(4-
fluorophenyl)-4-methoxy-1H-indazole (11): the results are shown in table 4. For both 
indazoles, the conversion was very good (80% and 88%), while the yield was low (19% 
and 5%), due to the formation of side products. 
Table 4 – Tandem borylation/oxidation of phenyl indazole.  
 
Entry Phenyl indazole Product Conversion Yield
c
 
1
a 
  
88% 19% 
2
b 
 
 
80% 5% 
a
 Reaction conducted on a 0.5 mmol scale, 0.6 M. b Reaction conducted on a 0.4 mmol scale, 0.6 M. c Yield 
over two steps. 
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From NMR analysis it was clear that no reaction occurred in 3 position. After 
purification and structure elucidation, the OH group was found to be in the phenyl 
moiety, to give the ortho-phenol product 10a and 11a. 
We next investigated pyrazolopyrimidine systems. The results are shown in table 5. 
Table 5 - Tandem borylation/oxidation of pyrazolopyrimidine system. 
 
Entry Substrate Product Conversion Yield 
1
a
 
  
53% 13% 
2
b 
  
97% 35% 
a Reaction conducted on a 0.12 mmol scale, 0.3 M. b Reaction conducted on a 0.17 mmol scale, 0.4 M 
Substrate 4 (entry 1), reacted with a conversion of 53%. After purification and structure 
elucidation of the oxidized product 4b (13% yield), it was possible to state that the 
tandem reaction led to meta-phenol regioisomer. 
For 6-tert-butyl-1-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidine (1, entry 2), the 
conversion was 97%. From 
19
F NMR of crude product, the presence of two products in a 
ratio of 1,5:1 was observed. After purification and structure elucidation, the main product 
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was identified as the meta-phenol regioisomer 1a (35% yield). The minor product was 
isolated and was identified as the meta-diol 1b (34% yield, figure 16). 
Figure 16 – Secondary product obtained from tandem reactions of substrate 1. 
 
Comparing the results in table 3,4 and 5 (reaction carried out under the same condition), 
a different regioselectivity can be noticed. As reported in literature, borylation of 1-
protected-1H-idazoles (with alkyl protecting group such as methyl, Bn, SEM, THP), 
usually occurs at the 3-position
35
 (figure 17A). This kind of regioselectivity was followed 
when borylation was carried out with 1-methyl-1H-indazoles (table 3). As a 
consequence, we expected that also 1-phenyl indazoles and 1-phenyl pyrazolopyrimidine 
could react with B2Pin2 at the 3-position of the pyrazole ring. However a different 
regioselectivity was followed, since for substrates 1, 4, 10 and 11 (table 4 and 5), the 
borylation occurred in the arylic substituent (figure 17B). 
Figure 17 – Different regioselectivity for indazoles and pyrazolopyrimidine. PG = protecting group. 
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Moreover, the reaction in the p-fluorophenyl substituent occurred at different position, 
since  we got ortho regioisomers for products 4a, 10a, 11a and meta-phenols for products 
1a and 4b. In order to figure out the reasons of this strange regioselectivity, we focused 
on the procedures that were used to run the borylation. 
Since we had many compounds to screen, we prepared a stock solution containing the 
active catalyst and THF. Then, an aliquot of the stock solution was added to the 
substrates. The preparation of the stock solution consisted of two steps: 
1- making of a mixture of B2Pin2, [Ir(COD)OMe]2, Me4phen and THF; 
2- heating of the mixture at 80 °C for 1h in a microwave reactor. 
Two different protocols were followed in the formation of the mixture of Iridium, ligand, 
B2Pin2 and solvent: 
- method A: [Ir(COD)OMe]2, Me4phen and THF were added in a vial and later 
poured into a different vial, where B2Pin2 was previously weighed (figure 18); 
- method B: [Ir(COD)OMe]2 and THF were added to a vial; Me4phen and THF 
were added to a different vial; both mixtures were poured in a vial where B2Pin2 
was previously weighed (figure 18).
Figure 18 – Method of preparation of stock mixture. MW = microwave. 
 
While a sample was prepared with method B, we noticed that the Me4phen had low 
solubility in THF ([Ir(COD)OMe]2 and B2Pin2 were totally soluble). To arrange the 
active catalyst in the right way, it was necessary a ratio of 2:1 between Me4phen and 
[Ir(COD)OMe]2. But, because the Me4phen solubility was an issue, when the ligand/THF 
mixture was poured into the B2Pin2 vial (method A and B), it was impossible to know 
MW 
MW 
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how much ligand the mixture would contain. So we could have stock solutions with the 
right ratio between ligand and metal, stock solutions with the wrong ratio or stock 
solutions with no ligand, each reacting in a different way and leading to different 
product. 
Therefore we decided to run some reactions without ligand and some reactions with a 
procedure that would guarantee the right ratio between Me4phen and [Ir(COD)OMe]2: 
- protocol C: the substrate, B2Pin2, [Ir(COD)OMe]2 and THF were added in a vial. 
The mixture was heated at 80 °C overnight; 
- protocol D: [Ir(COD)OMe]2 and THF were added to a vial and later poured into a 
different vial, where B2Pin2 and Me4phen were previously weighed. The mixture 
was heated at 80 °C for 1h in a microwave reactor to form a stock solution. The 
stock solution and the substrate were later added to the same vial that was heated 
at 80 °C overnight. 
The protocols C and D were ran on substrates 1, 4 and 10. The results obtained with 
protocol C are shown in table 6. For all the substrates, the regioselectivity led to the 
ortho-phenol in all the experiments. 
For substrate 10 (entry 1), the conversion was very good (87%) and the ortho-phenol 10a 
(35% yield) was the main product. Also the ortho-diol 10b (figure 19) was isolated (4% 
yield). 
Figure 19 - Secondary products from the reactions in table 5.   
 
Five reactions were run on substrate 1 and for all of them the ortho-phenol 1c was 
obtained. Also the ortho-diol 1d (figure 19) was isolated. In the entries 4 and 5 the yield 
for the mono phenol was 24% and 25%. When the reaction was run with 0,5 eq. of 
B2Pin2 (entry 6), an increase of selectivity to product 1c was observed (M:D = 7.5:1), 
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together with a decrease in conversion (60% against 94% and 75% of entries 4 and 5), 
but with a similar value of yield (22%). 
Table 6 - Tandem borylation/oxidation with protocol C. 
 
Substrate Entry Product Conv
f
 Yield
g
 M:D
h
 
 
1
a
 
 
87% 35% 2.13:1 
 
2
b
 
 
82% - 1.54:1 
3
a
 75% - 5.24:1 
 
4
a 
 
94% 24% (30%) 1:1.47 
5
a
 75% 25% (7%) 2.33:1 
6
c
 60% 22% (3%) 7.5:1 
7
d
 92% - 1:1.36 
8
e
 56% - 3.15:1 
a Reaction conducted on a 0.17 mmol scale, 0.4 M. b Reaction conducted on a 0.12 mmol scale, 0.6 M. c 
Reaction conducted on a 0.17 mmol scale, 0.4 M, B2Pin2 0.5 eq.. 
d Reaction conducted on a 0.17 mmol 
scale, 0.4 M, over weekend. e Reaction conducted on a 0.17 mmol scale, 0.4 M, over weekend, B2Pin2 0.5 
eq.. f Conversion. g In parentheses the yield of ortho diol product. h Ratio between ortho mono and ortho 
diol calculated from crude mixture 19F NMR. 
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In entries 7 and 8 the reaction were ran over weekend. When 1 eq. of B2Pin2 was used, 
high conversion was obtained and 1d was the main product. On the other hand, with 0,5 
eq. of B2Pin2, a lower conversion was obtained and 1c was the main product. 
Considering the results for substrate 1, an optimization of the borylation reaction 
condition, would lead to better values of selectivity and conversion. 
For the entries 4, 5 and 6 the product 1c was purified and the structure was solved by 
NMR analysis. In the last two experiments (entries 7 and 8), no purification was done: 
the structure of the product was confirmed by comparing the 
19
F NMRs of the crude 
mixtures with the spectrum of the crude of entry 5 (figure 20).  The peak around 117 ppm 
is the unconverted substrate 1; the peak around 114.75 ppm is the product 1c; the peak 
around 112.7 ppm is the product 1d. 
Figure 20 - Comparison between spectra of entries 5, 7 and 8. 
 
For substrate 4 (entries 2 and 3), the conversion was good (82% and 75%), and both 
products 4c and 4d were observed. Nevertheless, the crude mixtures were not purified: 
they were combined and another synthetic step was done on them. The purpose was to 
convert the products 4c and 4d in the molecules 1c and 1d, through a coupling reaction 
(scheme 23).  
Entry 5 
Entry 7 
Entry 8 
1 1c 
1d 
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Scheme 23 - Coupling reaction for molecule 4c to 1c. 
 
The product 1c was isolated to give a 6% yield over three steps (borylation, oxidation 
and coupling). To prove the structure, its 
19
F NMR was compared with the spectrum of 
the pure compound in the entry 5 (figure 21). The match was perfect, thus confirming the 
presence of the ortho-phenol. The ortho-diol product wasn´t observed and it was likely 
lost during the reaction work up. 
Figure 21 - 
19
F NMR comparison between the coupled product and the product from entry 5. 
 
The results obtained with protocol D are shown in table 7. For all the substrates, the 
regioselectivity led to the meta-phenol in all the experiments. 
Entry 5 (─) 
 
Coupled product (─) 
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Table 7 - Tandem borylation/oxidation with protocol D. 
 
Substrate Entry Product Conv
b
 Yield
c
 M:D
d
 
 
1
a
 
 
~ 90% - - 
 
2
a
 
 
45% - - 
 
3
a
 
 
100% 
37% 
(32%) 
1.35:1 
a Reaction conducted on a 0.17 mmol scale, 0.4 M. b Conversion. c In parentheses the yield of ortho diol 
product.  d Ratio between ortho mono and ortho diol calculated from crude mixture 19F NMR. 
For substrate 10 (entry 1), high conversion was obtained (~ 90%). From NMR of crude 
product, a complex mixture with five main products was observed, therefore we decided 
to skip the purification step. Likely, borylation occurred both in the aryl substituent and 
in the aromatic ring fused with the pyrazol. However, we compared the 
19
F NMR of the 
crude mixture with the spectrum of the pure ortho-phenol 10a (table 6, entry 1). The 
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peak of the ortho regioisomer didn´t fit with any peaks of the crude mixture. So it could 
be possible that the borylation occurred in the meta position of the aryl substituent. 
The tandem reactions for substrate 1 (entry 3), with a 100% conversion, led to both 
product 1a (37% yield) and 1b (32% yield). 
For substrate 4 (entry 2), the conversion was 45%, and only the mono phenol 4b was 
observed. Nevertheless the crude mixture wasn´t purified and another synthetic step was 
done on it. The purpose was to convert the products 4b in the molecule 1a, through a 
coupling reaction (scheme 24). 
Scheme 24 - Coupling reaction for molecule 4b and 1a. 
 
The product 1a was isolated to give a 5% yield over three steps (borylation, oxidation 
and coupling). To prove the structure, its 
19
F NMR was compared with the spectrum of 
the pure compound in the entry 3 (figure 22). The match between the peaks confirmed 
the presence of the meta-phenol regioisomer. 
Figure 22 - 
19
F NMR comparison between the coupled product and the product from entry 3. 
 
Entry 3 (─) 
 
Coupled product (─) 
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The results in tables 6 and 7 show different regioselectivity, depending on the procedure 
that was used to run the experiments. The Ir-catalyzed borylation shows regioselectivity 
controlled by steric effects. When [Ir(COD)OMe]2 and Me4phen made up the catalytic 
system (protocol C), the Bpin ended up in the meta position, that is less hindered position 
in the phenyl substituent. Therefore, when protocol C is applied, a sterically controlled 
mechanism is followed. 
If the reaction is carried out with no ligand (protocol D), the borylation occurs in the 
ortho position. So, in this case, no steric effect is shown. It´s possible that the nitrogen at 
2-position could act as directing group. As a consequence it would drive the borylation to 
the closer C-H bond, which is placed in the ortho position of the arylic substituent. 
Since one of the procedure that we tested worked without ligand, no problems should 
arise by setting up the reactions outside the glovebox. The lack of Me4phen prevented the 
formation of the air sensitive catalyst, enabling the contact with air. 
So we decided to test 5-bromo-1-(4-fluorophenyl)-1H-indazole (14): protocol D was 
used and the samples were prepared both inside and outside the glovebox. The results are 
shown in table 8. 
Table 8 - Tandem Borylation/oxidation of 5-bromo-1-(4-fluorophenyl)-1H-indazole. 
 
Entry Glovebox Conversion Yield
a 
M:D
b
 
1 In 95% 14% (22%) 1:1.83 
2 Out 87% 27% (13%) 1.2:1 
a In parentheses the yield of ortho diol product 14b. b Ratio between ortho mono and ortho diol calculated 
from crude mixture 19F NMR. 
In both experiments high conversion was observed (95% and 87%). When the reaction 
was set up in the glovebox (entry 1), the ortho-phenol 14a was isolate in a 14% yield, 
while the main product was the ortho-diol 14b (22% yield). On the other hand, without 
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the glovebox (entry 2), the ratio between mono and diphenol was 1.2:1. The product 14a 
was isolated in 27% yield and the product 14b in 13% yield. 
Since the tandem borylation/oxidation worked also when the reactions were set up 
outside the glovebox, we demonstrated that would be possible to perform protocol C in 
an easier way. 
4 Conclusions 
The aim of the project was the development of a protocol, for the metal catalyzed C-H 
borylation of 1-phenyl-1H-pyrazolo[3,4-d]pyrimidine (figure 14), a compound with 
biological activity within an AstraZeneca’s project. 
A key feature in borylation, was the setting up of the reactions inside the glovebox, in 
order to avoid the deactivation of the active catalyst. In all the experiments the boron 
source was B2Pin2 and the metal was supplied by the complex [Ir(COD)OMe]2, since 
iridium has been widely reported in literature as one of the best metals in borylation 
reaction. Investigation of the borylation of 1-methyl-1H-indazoles (table 3), revealed that 
reactions conducted overnight with Me4phen as ligand, THF as solvent and 80 °C were 
more efficient than the reaction conducted overnight with dtbpy as ligand, MTBE as 
solvent and 55 °C. 
Borylation of indazoles has been reported to occur at the 2-position in the five-membered 
ring. Nevertheless, we found that aryl pyrazolopyrimidine and aryl indazoles react 
exclusively in the phenyl substituent. 
To showcase the potential of late stage functionalization, the substrates underwent a 
tandem borylation/functionalization (scheme 22). The crude product from the borylation 
reaction underwent oxidation with sodium perborate, in order to transform the boronic 
ester in an OH group. 
By following this one-pot procedure, substrate 1 could be easily transformed into the 
corresponding phenol. When the catalytic system Ir- Me4phen was used, the reactions led 
to the meta-phenol regioisomer 1a, since the borylation reaction followed a steric 
controlled mechanism. Also substrate 4 could be borylated yielding the same 
regioisomer: this was confirmed by transforming 4b in 1a (scheme 25). 
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Scheme 25 – Tandem borylation/oxidation leading to meta regioisomer. 
 
When the borylation reactions were carried out without Me4phen, the reactions led to the 
ortho-phenol regioisomer 1c, since in this case the nitrogen at the 2-positon in the 
pyrazole ring could act as directing group. Also substrate 4 could be borylated yielding 
the same regioisomer: this was confirmed by transforming 4c in 1c (scheme 26). 
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Scheme 26 – Tandem borylation/oxidation leading to ortho regioisomer. 
 
5 Experimental section 
General information 
Reagents and solvents were purchased from Sigma-Aldrich, Fluka, Enamine, Combi-
blocks, Strem and Alfa Aesar. All indazoles were purchased or taken from inhouse 
source. A part from 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ol, the other 
prazolopyrimidine substrate were synthesized using in-house protocol. All reagents, 
solvents and starting materials were used with no further purification. 
Borylation reactions requiring an inert atmosphere were conducted in a Braun gloveboxe. 
Experimental procedures that do not mention the use of an inert atmosphere were 
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conducted in air. THF used as a solvent for the borylation reactions was degassed with 
Argon for 45 minutes. Glassware was oven dried before all borylation reactions. 
TLCs were performed on Merck glass-backed plates with a silica gel layer. Microwave 
reactions were carried out in sealed vials using a Biotage microwave reactor. 
Flash chromatographies were performed with an automated Biotage instrument on pre-
packed silica SNAP cartridge. 
LC/MS analyses were recorded on a Waters ZMD, LC column x Terra MS C8 (Waters), 
detection with a HP 1100 MS-detector diode array. 
NMR spectra were recorded using a Neptune 500 MHz instrument, in CDCl3 solutions 
(CDCl3 
1
H = 7.26 ppm, 
13
C = 77.15 ppm). All chemical shifts are reported in ppm 
relative to TMS, and the coupling constants are reported in Hz. Multiplicities are 
reported using the following abbreviations; s (singlet), d (doublet), dd (doublet of 
doublet), ddd (double of double of doublet), dt (doublet of triplet), t (triplet), q (quartet), 
m (multiplet) and br (broad).  
Conversion was calculated from 
19
F NMR of the crude mixture through the ratio between 
the integrals of the peaks of products and reagent. The yield was calculated by weighing 
the product after purification. 
Due to patent reason, for 6-tert-butyl-1-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidine 
(7) and its derivatives, only NMR shifts for the fluorophenyl moiety are reported. 
Synthesis of 6-tert-butyl-1-(4-fluorophenyl)-1H-pyrazolo[3,4-
d]pyrimidin-4(5H)-one (3.4 mmol scale) 
 
5-amino-1-(4-fluorophenyl)-1H-pyrazole-4-carboxamide (755 mg, 3.43 mmol, 1 eq.) and 
ethyl pivalate (5.2 ml, 34.3 mmol, 10 eq.), were suspended in absolute ethanol (6 ml) in a 
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20 ml microwave vial equipped with a magnetic stirrer. Sodium ethoxide (8.3 ml, 22.2 
mmol, 6.5 eq.), was carefully added. Then the vial was sealed and heated for 45 minutes 
at 130 °C in a microwave reactor. The reaction was cooled down at room temperature, 
diluted with EtOAc and brine, and poured in a separatory funnel. The pH was adjusted to 
7 by addition of HCl (3.8 M), and the water layer was extracted three times with EtOAc 
(20 ml). The combined organic extracts were filtered through a phase separator and 
concentrated with a rotary evaporator. LC-MS and NMR were run on the crude product. 
The residue was purified by automated flash chromatography on a Biotage® KP-SIL 
100g column. A gradient from 20% to 60% of EtOAc in heptane over 10CV was used as 
mobile phase. The product was collected using the wavelength 280 nm. The collected 
fractions were concentrated at the rotary evaporator and 6-tert-butyl-1-(4-fluorophenyl)-
1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one was obtained as a white solid. 
1
H NMR 500 MHz, CDCl3, δ (ppm): 1.48 (s, 9H), 7.17 – 7.23 (m, 2H), 8.13 – 8.18 (m, 
2H), 8.21 (s, 1H), 10.23 (s, 1H). 
19
F NMR 500 MHz, CDCl3, δ (ppm): -115.15. 
Synthesis of 6-tert-butyl-1-(4-fluorophenyl)-1H-pyrazolo[3,4-
d]pyrimidin-4(5H)-one (6.8 mmol scale) 
 
5-amino-1-(4-fluorophenyl)-1H-pyrazole-4-carboxamide (1500 mg, 6.8 mmol, 1 eq.) and 
ethyl pivalate (10.3 ml, 68 mmol, 10 eq.), were suspended in absolute ethanol (12 ml) in 
a two neck 100 ml round bottom flask, equipped with a condenser, a septa and as 
magnetic stirrer. Sodium ethoxide (19 ml, 51 mmol, 7.5 eq.), was carefully added. The 
flask was kept under a nitrogen atmosphere and went under reflux for 24 hours. The 
reaction was cooled down at room temperature, diluted with EtOAc and brine, and 
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poured in a separatory funnel. The pH was adjusted to 7 by addition of HCl (3.8 M), and 
the water layer was extracted three times with EtOAc (20 ml). The combined organic 
extracts were filtered through a phase separator and concentrated with a rotary 
evaporator. LC-MS and NMR were run on the crude product. The residue was purified 
by automated flash chromatography on a Biotage® KP-SIL 100g column. A gradient 
from 20% to 60% of EtOAc in heptane over 10CV was used as mobile phase. The 
product was collected using the wavelength 280 nm. The collected fractions were 
concentrated at the rotary evaporator and 6-tert-butyl-1-(4-fluorophenyl)-1H-
pyrazolo[3,4-d]pyrimidin-4(5H)-one was obtained as a white solid. 
1
H NMR 500 MHz, CDCl3, δ (ppm): 1.48 (s, 9H), 7.17 – 7.23 (m, 2H), 8.13 – 8.18 (m, 
2H), 8.21 (s, 1H), 10.23 (s, 1H). 
19
F NMR 500 MHz, CDCl3, δ (ppm): -115.15. 
Procedure for the amination of 6-tert-butyl-1-(4-fluorophenyl)-1H-
pyrazolo[3,4-d]pyrimidin-4(5H)-one 
 
6-tert-butyl-1-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one (440 mg, 1.54 
mmol, 1 eq.) and PyBOP (962 mg, 1.85 mmol, 1.2 eq.) were dissolved in DMF (11 ml), 
in a 50 ml round bottom flask equipped with a magnetic stirrer. DBU (1M in ethyl 
acetate) (2.3 mL, 2.31 mmol, 1.5 eq.) and R1HNR2 (1,5 eq.) were added to the flask. The 
mixture was stirred at room temperature overnight. The reaction mixture was diluted 
with EtOAc (20 ml). The organic phase was washed twice with sodium bicarbonate (8%) 
and twice with brine. Later the organic phase was filtered through a phase separator and 
concentrated with a rotary evaporator. The residue was purified by automated flash 
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chromatography on a Biotage® KP-SIL 100g  column. A gradient from 20%  to  60% of 
EtOAc in heptane over 10CV was used as mobile phase. The product was collected using 
the wavelength 280 nm. The collected fractions were concentrated at the rotary 
evaporator and 6-tert-butyl-1-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidine (7) was 
obtained as a transparent oil. 
1
H NMR 500 MHz, CDCl3, δ (ppm): 7.18 (t, 2H), 8.29 – 8.42 (m, 2H). 
19
F NMR 500 MHz, CDCl3, δ (ppm): -117.06. 
General procedures for  tandem borylation/oxidation of 1-
phenyl indazoles and pyrazolopyrimidine 
A – Synthesis of meta-phenol regioisomer 
Inside a glovebox, di-μ-methoxobis(1,5-cyclooctadiene)diiridium (I) (4.51 mg), B2Pin2 
(172 mg), Me4phen (3.2 mg) and THF (0.8 ml) were added to a 2 ml microwave vial. 
The vial was equipped with a magnetic stirrer and sealed. It was taken out the glovebox 
and heated at 80 °C for 1h in a microwave reactor.  After that, inside a glovebox, 0.2 ml 
of the mixture of B2Pin2 (43 mg, 0.17 mmol, 1 eq.), [Ir(COD)OMe]2 (1.13 mg, 0.0017 
mmol, 1%) and Me4phen (0.8 mg, 0.0034 mmol, 2%), was added to a 2 ml vial (equipped 
with a magnetic stirrer), where the substrate (0.17 mmol) was previously added. To the 
vial was added 0.2 ml of THF. The vial was sealed and taken out from the glovebox. The 
vial was heated at 80 °C overnight. The reaction was cooled down at room temperature 
and the mixture was transferred to a 10 ml vial, equipped with a magnetic stirrer. The 
reaction mixture was diluted with 4 ml of THF and 4 ml of water. Then sodium perborate 
(78 mg, 0.51 mmol, 3 eq.) was added and the vial was stirred at room temperature for 1h. 
The reaction mixture was diluted with EtOAc (20 ml) and later poured into a separatory 
funnel, where it was washed with ammonium chloride (10%, 20 ml). The organic phase 
was filtered through a phase separator and concentrated with a rotary evaporator. The 
residue was purified by automated flash chromatography on a Biotage® KP-SIL 25g 
column. A gradient from 30% to 80% of EtOAc in heptane over 10CV was used as 
mobile phase. The product was collected using the wavelength 250 nm. The collected 
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fractions were concentrated at the rotary evaporator and the meta phenol product was 
obtained. 
1-(4-fluoro-3-hydroxyphenyl)-1H-indazole-5-carbonitrile 
The synthesis was conducted according to the general procedure 
with 1-(4-fluorophenyl)-1H-indazole-5-carbonitrile (40 mg), as 
starting material. In the 
19
F NMR of the crude mixture, five 
products were observed. Therefore no further purification was 
done. 
6-tert-butyl-1-(4-fluoro-3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one 
The synthesis was conducted according to the general 
procedure with 6-tert-butyl-1-(4-fluorophenyl)-1H-
pyrazolo[3,4-d]pyrimidin-4(5H)-one (48 mg), as starting 
material. 
1
H NMR 500 MHz, DMSO, δ (ppm): 1.37 (s, 9H), 7.31 (dd, 
1H), 7.60 (dt, 1H), 7.76 (dd, 1H), 8.24 (s, 1H), 10.32 (s, 1H), 
11.98 (s, 1H). 
13
C NMR 500 MHz, DMSO, δ (ppm) 27.86 (CH3), 37.61 (C), 105.45 (C), 110.77 (CH), 
111.82 (CH, J = 19.6), 116.32 (CH, J = 19.6), 134.95 (C), 135.59 (CH), 145.12 (C), 
149,52 (C), 167.30 (C). 
19
F NMR 500 MHz, DMSO, δ (ppm): -138.31. 
1-(4-fluoro-3-hydroxyphenyl)-pyrazolopyrimidine  
The synthesis was conducted according to the general 
procedure with 1-(4-fluorophenyl)-1H-pyrazolopyrimidine as 
starting material. 
1
H NMR 500 MHz, CDCl3, δ (ppm): 7.17 (t, 1H), 7.92 (dt, 
1H), 8.13 (dd, 1H). 
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13
C NMR 500 MHz, CDCl3, δ (ppm): 110.60 (CH), 113.26 (CH, J = 6.4), 115.57 (CH, J 
= 19.1), 136.56 (C, J = 3), 143.72 (C, J = 14.9), 149.00 C, (J = 237). 
19
F NMR 500 MHz, CDCl3, δ (ppm): -144.03 
B – Synthesis of ortho-phenol regioisomer 
Inside a glovebox di-μ-methoxobis(1,5-cyclooctadiene)diiridium (I) (16.9 mg) and THF 
(3 ml), were added to a 5 ml vial. In a different 5 ml vial B2Pin2 (129 mg) and THF (0.6 
ml) were added. In a 2 ml vial was weighed the substrate (0.17 mmol) and later 0.2 ml of 
[Ir(COD)OMe]2 solution (1.13 mg, 0.0017 mmol, 1%) and 0.2 ml of B2Pin2 solution (43 
mg, 0,17 mmol, 1 eq.), were added. The vial was taken out from the glovebox and heated 
at 80 °C overnight. The reaction was cooled down at room temperature and the mixture 
was transferred to a 10 ml vial, equipped with a magnetic stirrer. The reaction mixture 
was diluted with 4 ml of THF and 4 ml of water. Then sodium perborate (78 mg, 0.51 
mmol, 3 eq.) was added and the vial was stirred at room temperature for 1h. The reaction 
mixture was diluted with EtOAc (20 ml) and later poured into a separatory funnel, where 
it was washed with ammonium chloride (10%, 20 ml). The organic phase was filtered 
through a phase separator and concentrated with a rotary evaporator. The residue was 
purified by automated flash chromatography on a Biotage® KP-SIL 25g column. A 
gradient from 30% to 80% of EtOAc in heptane over 10CV was used as mobile phase. 
The product was collected using the wavelength 250 nm. The collected fractions were 
concentrated at the rotary evaporator and the ortho phenol product was obtained. 
1-(4-fluoro-2-hydroxyphenyl)-1H-indazole-5-carbonitrile 
The synthesis was conducted according to the general 
procedure with 1-(4-fluorophenyl)-1H-indazole-5-carbonitrile 
(40 mg), as starting material. To perform the flash 
chromatography, a gradient from 25% to 65% of EtOAc in 
heptane over 10CV was used as mobile phase. 
1
H NMR 500 MHz, CDCl3, δ (ppm): 6.80 (ddd, 1H), 6.94 (dd, 
1H), 7.51 (dd, 1H), 7.70 (dd, 1H), 7.83 (d, 1H), 8.25 – 8.27 (m, 1H), 8.37 – 8.4 (m, 1H), 
8.88 (s, 1H). 
51 
 
13
C NMR 500 MHz, CDCl3, δ (ppm): 106.30 (C), 106.56 (CH, J = 25.7), 107.51 (CH, J 
= 23.4), 118.99 (C), 121.77 (C, J = 3.0), 122.93 (CH, J = 10.4), 123.92 (C), 128.23 (CH), 
130.31 (CH), 135.96 (CH), 139.84 (C), 151.73 (C, J = 12.7), 162.44 (C, J = 247.8). 
19
F NMR 500 MHz, CDCl3, δ (ppm): -110.92 
6-tert-butyl-1-(4-fluoro-2-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one 
The synthesis was conducted according to the general 
procedure with 6-tert-butyl-1-(4-fluorophenyl)-1H-
pyrazolo[3,4-d]pyrimidin-4(5H)-one (48 mg) as starting 
material. 
 
 
1-(4-fluoro-2-hydroxyphenyl)-pyrazolopyrimidine 
The synthesis was conducted according to the general 
procedure with 1-(4-fluorophenyl)-1H-pyrazolopyrimidine 
as starting material. 
1
H NMR 500 MHz, CDCl3, δ (ppm): 6.67 – 6.77 (m, 1H), 
6.85 (dd, 1H), 7.89 (dd, 1H), 12.24 (s, 1H). 
13
C NMR 500 MHz, CDCl3, δ (ppm): 107.43 (CH, J = 8.0, 
23.6), 124.93 (CH, J = 10.3), 125.02 (C), 150.17 (C, J = 
12.5), 162.47 (C, J = 245.6). 
19
F NMR 500 MHz, CDCl3, δ (ppm): -144.77. 
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2-(5-bromo-1H-indazol-1-yl)-5-fluorophenol 
The synthesis was conducted according to the general 
procedure with 5-bromo-1-(4-fluorophenyl)-1H-indazole (49 
mg), as starting material. To perform the flash 
chromatography, a gradient from 10% to 80% of EtOAc in 
heptane over 14CV was used as mobile phase. 
1
H NMR 500 MHz, CDCl3, δ (ppm): 6.76 (td, 1H), 6.91 (dd, 
1H), 7.51 (dd, 1H), 7.56 – 7.6 (m, 1H), 7.65 (d, 1H), 8.00 (s, 1H), 8.20 (s, 1H), 9.32 (s, 
1H). 
13
C NMR 500 MHz, CDCl3, δ (ppm): 106.33 (CH, J = 25.6), 107.12 (CH, J = 23.3), 
112.28 (CH), 115.54 (C), 122.22 (C), 122.30 (CH), 124.28 (CH), 125.86 (C), 131.56 
(CH), 134.20 (CH), 137.75 (C), 151.58 (C, J = 12.7), 161.98 (C, J = 246.4). 
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